AGP Executive Report
Last update: 12 hours agoFDA & Devices: The FDA cleared TriSalus Life Sciences’ TriNav Advance to help interventional radiologists reach smaller, distal vessels during liver embolization, aiming for more precise delivery. Rare Disease Drug: Mirum Pharma’s oral Atebrioz (zilurgisertib) won FDA approval for fibrodysplasia ossificans progressiva (FOP) for patients 12+ and adults, adding a new daily option. Corruption Probe: South Africa’s SIU secured about R42.4m in assets tied to alleged bribes at Tembisa Hospital, with preservation orders and pension/property freezes. Public Health & Outbreaks: South Australia’s measles cluster tied to Brighton Secondary School grew to five cases, with a patient spending over 24 hours in an Adelaide hospital ED. Healthcare Policy: A US bill modeled on Oregon would limit private equity control of medical practices, with ownership rules favoring practicing clinicians. Workforce & Pay: Reports from China describe hospital pay cuts, unpaid wages, and reduced bonuses hitting nurses and other staff. Safety & Infrastructure: Pakistan’s health minister ordered a nationwide review of fire safety and core infrastructure across hospitals and rural health centers. Community Care: Liberia and Ghana went live with OneHealthEHR’s offline-first records and disease surveillance platform. Clinical/Legal: India’s CDSCO warned against repeated or prolonged NSAID and antibiotic use without medical advice, citing kidney risks and misuse concerns.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
